Nguyen T D, Wolfe M S, Heintz G G
Division of Gastroenterology, Duke University, Durham, North Carolina.
Am J Physiol. 1995 Feb;268(2 Pt 1):G215-23. doi: 10.1152/ajpgi.1995.268.2.G215.
We have previously identified, on rat liver microsomes and plasma membranes, proteins that bind pancreatic polypeptide (PP) with high affinity and specificity and that may serve as receptors for a hepatic effect of PP (J. Biol. Chem. 267: 9416-9421, 1992). Further characterization of these proteins requires the solubilization of receptors with conserved ability to bind PP selectively and efficiently. In this report, using 6 mM of the zwitterionic detergent 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), we solubilized, from liver microsomes, receptors that bound PP with high affinity (dissociation constant 6.15 +/- 1.6 nM) and specificity (no interaction with the homologous peptides neuropeptide Y and peptide YY). Gel filtration chromatography showed different degrees of receptor aggregation related to different concentrations of CHAPS in the eluent. To characterize the structure of these solubilized receptors, the chemical cross-linker N-(5-azido-2-nitrobenzoyloxy)succinimide was used to covalently bind these receptors to radiolabeled PP, and the resulting PP-receptor complexes were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A radioactive band with an apparent molecular weight (M(r)) of 46,000 was detected that was inhibited by unlabeled PP with a half-maximal inhibitory concentration of approximately 10(-8) M. It most likely reflected a PP receptor with an estimated M(r) of 42,000, excluding the molecular weight of PP. The migration of this complex was not affected by the reducing agent dithiothreitol, suggesting the absence of disulfide bonding. The solubilization and identification of a bioactive hepatic PP receptor will allow further characterization and purification of this receptor and will lead to the clarification of the interaction between PP and the digestive system.
我们之前在大鼠肝微粒体和质膜上鉴定出了能以高亲和力和特异性结合胰多肽(PP)的蛋白质,这些蛋白质可能作为PP肝脏效应的受体(《生物化学杂志》267: 9416 - 9421, 1992)。对这些蛋白质的进一步表征需要溶解具有选择性和高效结合PP保守能力的受体。在本报告中,我们使用6 mM两性离子去污剂3 - [(3 - 胆酰胺丙基)-二甲基铵]-1 - 丙烷磺酸盐(CHAPS),从肝微粒体中溶解出了能以高亲和力(解离常数6.15 ± 1.6 nM)和特异性(与同源肽神经肽Y和肽YY无相互作用)结合PP的受体。凝胶过滤色谱显示,洗脱液中不同浓度的CHAPS与不同程度的受体聚集有关。为了表征这些溶解受体的结构,使用化学交联剂N - (5 - 叠氮 - 2 - 硝基苯甲酰氧基)琥珀酰亚胺将这些受体与放射性标记的PP共价结合,然后通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳分析所得的PP - 受体复合物。检测到一条表观分子量(M(r))为46,000的放射性条带,未标记的PP对其具有抑制作用,半最大抑制浓度约为10(-8) M。它很可能反映了一种估计M(r)为42,000的PP受体,不包括PP的分子量。该复合物的迁移不受还原剂二硫苏糖醇的影响,表明不存在二硫键。生物活性肝脏PP受体的溶解和鉴定将有助于对该受体进行进一步表征和纯化,并将有助于阐明PP与消化系统之间的相互作用。